A best evidence topic was constructed according to a structured protocol. The question addressed was whether 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) aids the diagnosis of prosthetic valve endocarditis (PVE)? A total of 107 publications were found using the reported search, of which 6 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. The reported outcome of all studies was a final diagnosis of confirmed endocarditis on follow-up. All the six studies were non-randomized, single-centre, observational studies and thus represented level 3 evidence. The diagnostic capability of PET/CT for PVE was compared with that of the modified Duke Criteria and echocardiography, and reported in terms of sensitivity, specificity and positive and negative predictive values. All studies demonstrated an increased sensitivity for the diagnosis of PVE when PET/CT was combined with the modified Duke Criteria on admission. A higher SUV max on PET was found to be significantly associated with a confirmed diagnosis of endocarditis and an additional diagnostic benefit of PET/CT angiography over conventional PET/non-enhanced CT is reported due to improved anatomical resolution. However, PET/CT was found to be unreliable in the early postoperative period due to its inability to distinguish between infection and residual postoperative inflammatory changes. PET/CT was also found to be poor at diagnosing cases of native valve endocarditis. We conclude that PET/CT aids in the diagnosis of PVE when combined with the modified Duke Criteria on admission by increasing the diagnostic sensitivity. The diagnostic ability of PET/CT can be potentiated by the use of PET/CTA; however, its use may be unreliable in the early postoperative period or in native valve endocarditis.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol as fully described in ICVTS [1] .
THREE-PART QUESTION

In [ patients with previous prosthetic valve implantation] does [the use of PET/CT] aid [the diagnosis of infective endocarditis]?
CLINICAL SCENARIO
A 54-year old gentleman is admitted with low-grade fever and general malaise at 6 months following aortic valve replacement for infective endocarditis. On admission, he is noted to have an ejection systolic murmur in keeping with his tissue aortic valve and no obvious sources of infection. His inflammatory markers are raised, and blood cultures on admission grew Staphylococcus aureus. Transoesophageal echocardiography demonstrates moderate aortic regurgitation and no obvious vegetations. You suspect the patient may have prosthetic valve endocarditis (PVE) and have heard that positron emission tomography/computed tomography (PET/CT) scanning has been reported as aiding diagnosis in this setting. You are not aware of the current evidence supporting its use and decide to review the literature. 
SEARCH STRATEGY
SEARCH OUTCOME
A total of 107 publications were found using the reported search. Of these, six represented the best available evidence to answer the clinical question. These are summarized in Table 1 . 
Continued
RESULTS
All studies compared the diagnostic ability of PET/CT scan with a 'final diagnosis' gold standard. The exact method of determining this gold standard varied between studies but in all cases was based on a combination of the modified Duke's Criteria, imaging and microbiological findings over the follow-up period (ranging from hospital discharge to 3 months). Where further information such as intraoperative findings and histology were available, these were included in the final diagnostic criteria. Saby et al. [2] were the first to conduct a study of the diagnostic impact of PET/CT in the setting of PVE. In their prospective observational study of 72 patients with suspected PVE on admission, the addition of a positive PET/CT scan as a major criterion in the modified Duke Criteria (DC) significantly increased its sensitivity from 70 to 97% (P < 0.008) without a significant reduction in specificity. This increase was attributed to a significant reduction in cases classified as 'possible PVE' from 40 to 23 (P < 0.0001). However, it should be noted that part of this reclassification resulted in 10 of 22 patients originally correctly classified as 'possible PVE' being incorrectly reclassified as 'definite PVE'. The clinical implications of this are not known. The SUV max on PET/CT in cases of 'definite PVE' was also significantly increased in comparison with cases of possible or rejected PVE (P < 0.05).
Bartoletti et al. [3] reported a small case series of 6 patients with suspected aortic PVE and negative echocardiographic findings. Final diagnoses were based on histology in 4 cases and by clinical response to treatment in the remaining 2 cases. PET/CT successfully diagnosed PVE in all 6 cases and showed a consistent reduction in SUV max on repeat scanning following antibiotic therapy.
Ricciardi et al. [4] conducted a retrospective study of 22 patients with suspected endocarditis (15 PVE and 7 native valve endocarditis). PET/CT had a greater sensitivity for detecting confirmed PVE at 85% compared with 77% for transthoracic echocardiography/ transoesophageal echocardiography and 77% for DC on admission. However, in 7 patients with native valve endocarditis, PET/CT failed to detect infection in all cases (P < 0.001). As such, the authors advise against the use of PET/CT in this setting.
Rouzet et al. [5] compared PET/CT and single-photon emission computed tomography (SPECT) in the diagnosis of 92 cases of suspected PVE with inconclusive echocardiographic results. PET/CT was found to be a more useful initial test due to its greater sensitivity for PVE (93 vs 64%) although SPECT had a greater specificity (100 vs 71%). This reduced specificity was in part due to 6 cases of false-positive PET/CT results, all of which were within 2 months of F-fluorodeoxyglucose uptake in inflammatory tissues can mimic infection and result in false-positives in this time period. When patients within 2 months of prosthetic valve implantation were excluded from the analysis, the sensitivity and specificity of PET/CT for detecting PVE were 92 and 100%, respectively.
Pizzi et al. [6] analysed the relative performance of PET/CT and PET/CT angiography (PET/CTA) in the diagnosis of patients with suspected PVE and cardiac device-related endocarditis. They report that adding PET/CT to modified DC on admission significantly increased diagnostic sensitivity for patients with PVE from 51 to 90% (P-value not quoted). PET/CTA was found to confer an additional advantage of PET/non-enhanced CT (PET/NECT) by reducing the number of possible cases on PET/NECT from 20 to 8% (P < 0.001). PET/CTA offers additional diagnostic ability due to its use of ECG-gated, contrast-enhanced anatomical images. In a similar result to that demonstrated by Saby et al., SUV max was significantly higher in cases of definite PVE (median SUV max of 7.36 for definite PVE; 2.37 for possible PVE and 0.5 for rejected PVE).
Fagman et al. [7] performed a prospective study that included a control group of patients with prosthetic valves undergoing PET scan for malignancy. They showed that SUV max and SUV ratio were both significantly lower in this cohort than in a cohort of 8 patients with a final diagnosis of definite PVE. They also showed good diagnostic ability of PET/CT for PVE, but this result was not contextualized by comparison with any other methods such as the modified DC or echocardiography.
CLINICAL BOTTOM LINE
Current evidence suggests that PET/CT aids the diagnosis of PVE when combined with the modified DC on admission by increasing the diagnostic sensitivity. The diagnostic ability of PET/CT can be potentiated by the use of PET/CTA. However, PET/CT is unreliable in the early postoperative period or in native valve endocarditis.
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